PKCθ/β and CYLD Are Antagonistic Partners in the NFκB and NFAT Transactivation Pathways in Primary Mouse CD3⁺ T Lymphocytes

• Nikolaus Thuille,

  Affiliation Department of Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria

  ⨯
• Katarzyna Wachowicz,

  Affiliation Department of Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria

  ⨯
• Natascha Hermann-Kleiter,

  Affiliation Department of Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria

  ⨯
• Sandra Kaminski,

  Affiliation Department of Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria

  ⨯
• Friedrich Fresser,

  Affiliation Department of Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria

  ⨯
• Christina Lutz-Nicoladoni,

  Affiliation Department of Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria

  ⨯
• Michael Leitges,

  Affiliation The Biotechnology Centre of Oslo, Oslo, Norway

  ⨯
• Margot Thome,

  Affiliation Department of Biochemistry, University of Lausanne, Lausanne, Switzerland

  ⨯
• Ramin Massoumi,

  Affiliation Department of Laboratory Medicine, Lund University, Malmö, Sweden

  ⨯
• Gottfried Baier

  * E-mail: Gottfried.Baier@i-med.ac.at

  Affiliation Department of Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria

  ⨯